CSL's price guide increased

CSL's share price has increased 11% since CSL: Result 2014 from 14 Aug 14 (Hold – $67.24) and the stock currently trades on a forecast price-to-earnings ratio of 22. That’s a high price for most businesses but not CSL, as it's one of the few companies in Australia that could grow much bigger over the next ten years as new uses for blood products are found and healthcare budgets increase around the world. The plasma industry is also more concentrated than it's ever been, affording the three big players pricing power and lessening the risk of a price war...

CSL's share price has increased 11% since CSL: Result 2014 from 14 Aug 14 (Hold – $67.24) and the stock currently trades on a forecast price-to-earnings ratio of 22. That’s a high price for most businesses but not CSL, as it's one of the few companies in Australia that could grow much bigger over the next ten years as new uses for blood products are found and healthcare budgets increase around the world.

{{content.question}}

SMS Code Sent…

Hi {{ user.FirstName }}

Looks like you've already taken a free trial

Please enter your payment details

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

If you didn't receive SMS code please

Looks you are already a member. Please enter your password to proceed

Please untick this box when using a public or shared device


Verify your mobile number

Please sign up for full access

Updating information

Please wait ...

  • Mastercard
  • Visa

Related Articles